Fig. 3.
Faecal bacterial alpha diversity of volunteers with relapsing multiple sclerosis (RMS) infected with Necator americanus (N+) or placebo-treated (PBO). a Mixed effect linear regression indicating differences in bacterial Shannon diversity within and between N+ and PBO subjects 1 week prior to infection/placebo treatment (Tpre), at 1, 5, and 9 months post-infection/placebo treatment (Ttreatment), and 2 months post-anthelmintic treatment (Tpost). b Differences in faecal bacterial Shannon diversity between N+ (left panel) and PBO (right panel) subjects over the course of Ttreatment. *P < 0.05